These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3386282)

  • 1. Actions of oestrogens and antioestrogens on rat mammary gland development: relevance to breast cancer prevention.
    Nicholson RI; Gotting KE; Gee J; Walker KJ
    J Steroid Biochem; 1988; 30(1-6):95-103. PubMed ID: 3386282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
    Wakeling AE; Valcaccia B
    J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780.
    Hilakivi-Clarke L; Cho E; Raygada M; Kenney N
    J Cell Physiol; 1997 Mar; 170(3):279-89. PubMed ID: 9066785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
    Wakeling AE; O'Connor KM; Newboult E
    J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ospemifene on breast tissue morphology and proliferation: a comparative study versus other selective estrogen receptor modulators in ovariectomized rats.
    Kangas L; Härkönen P; Väänänen K; Keskitalo J; Eigéliené N
    Horm Metab Res; 2014 May; 46(5):328-32. PubMed ID: 24526372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens.
    Silberstein GB; Van Horn K; Shyamala G; Daniel CW
    Endocrinology; 1994 Jan; 134(1):84-90. PubMed ID: 8275973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland.
    Johnson MD; Kenney N; Stoica A; Hilakivi-Clarke L; Singh B; Chepko G; Clarke R; Sholler PF; Lirio AA; Foss C; Reiter R; Trock B; Paik S; Martin MB
    Nat Med; 2003 Aug; 9(8):1081-4. PubMed ID: 12858169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].
    Borgna JL
    Bull Cancer; 1994 Jan; 81(1):29-37. PubMed ID: 7949581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.
    Daniel CW; Silberstein GB; Strickland P
    Cancer Res; 1987 Nov; 47(22):6052-7. PubMed ID: 3664507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
    Raafat AM; Hofseth LJ; Haslam SZ
    Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of mammary-derived growth inhibitor messenger RNA by antiestrogens.
    Huynh H; Pollak M
    Clin Cancer Res; 1997 Nov; 3(11):2151-6. PubMed ID: 9815609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists.
    Skarda J; Köhlerová E
    J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):145-53. PubMed ID: 16533331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate.
    Chan TW; Mark G; Huynh H
    Int J Oncol; 2001 Aug; 19(2):263-9. PubMed ID: 11445837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid.
    Ruan W; Catanese V; Wieczorek R; Feldman M; Kleinberg DL
    Endocrinology; 1995 Mar; 136(3):1296-302. PubMed ID: 7867584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.
    Nishino Y; Schneider MR; Michna H; von Angerer E
    J Endocrinol; 1991 Sep; 130(3):409-14. PubMed ID: 1834757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland.
    Sourla A; Martel C; Labrie C; Labrie F
    Endocrinology; 1998 Feb; 139(2):753-64. PubMed ID: 9449650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens.
    Sutherland RL; Reddel RR; Green MD
    Eur J Cancer Clin Oncol; 1983 Mar; 19(3):307-18. PubMed ID: 6345171
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel antioestrogens without partial agonist activity.
    Wakeling AE; Bowler J
    J Steroid Biochem; 1988 Oct; 31(4B):645-53. PubMed ID: 3199810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.